Cargando…
Mutant IDH in Gliomas: Role in Cancer and Treatment Options
SIMPLE SUMMARY: Isocitrate dehydrogenase (IDH) is the most mutated metabolic gene in human cancer. Mutations in this gene have been identified in a high percentage of gliomas, in acute myeloid leukemia (AML) and in many other malignancies. Mutant IDH causes tumour initiation, possibly through accumu...
Autores principales: | Solomou, Georgios, Finch, Alina, Asghar, Asim, Bardella, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252079/ https://www.ncbi.nlm.nih.gov/pubmed/37296846 http://dx.doi.org/10.3390/cancers15112883 |
Ejemplares similares
-
Advances in Research of Adult Gliomas
por: Finch, Alina, et al.
Publicado: (2021) -
Updates on the WHO diagnosis of IDH-mutant glioma
por: Reuss, David.E.
Publicado: (2023) -
Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023) -
Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers
por: Unruh, Dusten, et al.
Publicado: (2019) -
Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas
por: Park, Jong-Whi, et al.
Publicado: (2019)